Hyderabad, April 30, 2007: Dr. Reddy's today announced Dr. Rajinder Kumar joining the company as its President- Research, Development & Commercialization.
will lead and integrate Discovery Research, Global Drug Development and Commercialization efforts, including differentiated products.
joins us at an exciting time.
brings in rich experience and the necessary management bandwidth to consolidate our new Chemical Entity (NCE) Research and drug development efforts.
expertise will help us accelerate our efforts to build a global innovation-led business."
Dr. Kumar graduated in Medicine and Surgery from the University of Dundee, UK and is an alumnus of acclaimed institutions like the University of London and University of Birmingham.
He is a member of several scientific and clinical organizations and is a Fellow of the Royal Society of Medicine and Member of the Institute of Directors, U.K.
After a distinguished academic and clinical career, Dr. Kumar spent a large part of his career at SmithKline Beecham and Glaxo SmithKline where he held key executive positions of Vice President and Director - Neuroscience and GI, Smith Kline Beecham, USA; Vice President & Global Head of Psychiatry, Clinical Development and Medical Affairs, Glaxo SmithKline.
He has also been the President, Research and Development, Ranbaxy Laboratories, India.
team were responsible for the development and implementation of the strategy for experimental medicines and life cycle management, leading to products of differentiated value with significant commercial impact.